Three MSI PIs are among the University faculty who have received seed grants from the Minnesota Partnership for Biotechnology and Medical Genomics. The Partnership is a collaboration between the University of Minnesota, Mayo Clinic, and the State of Minnesota that supports biotechnology and biomedical research. The projects receiving grants include researchers from the University and Mayo.
The PIs receiving awards are:
Professor Stephen Jameson, Laboratory Medicine and Pathology; Dr. Hirohito Kita, Mayo Clinic collaborator
Project Title: Testing susceptibility of “dirty” mice to induction of asthmatic disease
Professor Jameson uses MSI resources to support research into the function and development of immune cells.
Associate Professor Douglas Mashek, Biochemistry, Molecular Biology, and Biophysics; Dr. Mark McNiven, Mayo Clinic collaborator
Project Title: Screening for liver steatosis using genomics and small molecules
Professor Mashek uses MSI for studies of lipid droplet biology and its relationship to metabolic diseases.
Associate Professor Michael Walters, Medicinal Chemistry; Dr. Liwei Wang, Mayo Clinic collaborator
Project Title: Using precision medicine to study individual resistance to ER+ breast cancer inhibitors
Professor Walters uses MSI for a number of projects in translational medicine, currently including therapeutics or probes for muscular dystrophy, Alzheimer’s disease, cardiac valve calcification, and brain cancer.
An article showing a complete list of the grant awardees and descriptions of the projects can be found on the Partnership website: Minnesota Partnership Awards Six New Research Grants.